143 related articles for article (PubMed ID: 23022230)
1. Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation.
Pignatelli P; Carnevale R; Di Santo S; Bartimoccia S; Nocella C; Vicario T; Loffredo L; Angelico F; Violi F
Biochem Pharmacol; 2012 Dec; 84(12):1635-42. PubMed ID: 23022230
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes.
Miersch S; Sliskovic I; Raturi A; Mutus B
Free Radic Biol Med; 2007 Jan; 42(2):270-9. PubMed ID: 17189832
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.
Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A
J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
Whaley-Connell A; Habibi J; Nistala R; Cooper SA; Karuparthi PR; Hayden MR; Rehmer N; DeMarco VG; Andresen BT; Wei Y; Ferrario C; Sowers JR
Hypertension; 2008 Feb; 51(2):474-80. PubMed ID: 18172055
[TBL] [Abstract][Full Text] [Related]
6. Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment.
Pignatelli P; Di Santo S; Buchetti B; Sanguigni V; Brunelli A; Violi F
FASEB J; 2006 Jun; 20(8):1082-9. PubMed ID: 16770007
[TBL] [Abstract][Full Text] [Related]
7. Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.
Whaley-Connell AT; Morris EM; Rehmer N; Yaghoubian JC; Wei Y; Hayden MR; Habibi J; Stump CS; Sowers JR
Am J Nephrol; 2007; 27(1):15-23. PubMed ID: 17204833
[TBL] [Abstract][Full Text] [Related]
8. Effect of L-carnitine on oxidative stress and platelet activation after major surgery.
Pignatelli P; Tellan G; Marandola M; Carnevale R; Loffredo L; Schillizzi M; Proietti M; Violi F; Chirletti P; Delogu G
Acta Anaesthesiol Scand; 2011 Sep; 55(8):1022-8. PubMed ID: 21770897
[TBL] [Abstract][Full Text] [Related]
9. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment.
Coban E; Afacan B
Platelets; 2008 Mar; 19(2):111-4. PubMed ID: 17852772
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation.
Basili S; Raparelli V; Riggio O; Merli M; Carnevale R; Angelico F; Tellan G; Pignatelli P; Violi F;
Liver Int; 2011 Nov; 31(10):1533-40. PubMed ID: 22093328
[TBL] [Abstract][Full Text] [Related]
11. eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy.
Manucha W; Kurbán F; Mazzei L; Benardón ME; Bocanegra V; Tosi MR; Vallés P
Eur J Pharmacol; 2011 Jan; 650(2-3):487-95. PubMed ID: 20940012
[TBL] [Abstract][Full Text] [Related]
12. [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].
Sicard P; Lauzier B; Oudot A; Busseuil D; Collin B; Duvillard L; Moreau D; Vergely C; Rochette L
Arch Mal Coeur Vaiss; 2005; 98(7-8):804-8. PubMed ID: 16220751
[TBL] [Abstract][Full Text] [Related]
13. Glucose-regulated protein 78 and platelet deposition: effect of rosuvastatin.
Molins B; Peña E; Padro T; Casani L; Mendieta C; Badimon L
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1246-52. PubMed ID: 20360535
[TBL] [Abstract][Full Text] [Related]
14. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J
Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148
[TBL] [Abstract][Full Text] [Related]
15. Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.
Burma O; Onat E; Uysal A; Ilhan N; Erol D; Ozcan M; Sahna E
Cardiovasc J Afr; 2014; 25(5):212-6. PubMed ID: 25629537
[TBL] [Abstract][Full Text] [Related]
16. NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate.
Loffredo L; Carnevale R; Perri L; Catasca E; Augelletti T; Cangemi R; Albanese F; Piccheri C; Nocella C; Pignatelli P; Violi F
Heart; 2011 Nov; 97(21):1776-81. PubMed ID: 21807659
[TBL] [Abstract][Full Text] [Related]
17. Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2.
Pignatelli P; Carnevale R; Pastori D; Cangemi R; Napoleone L; Bartimoccia S; Nocella C; Basili S; Violi F
Circulation; 2012 Jul; 126(1):92-103. PubMed ID: 22615342
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
Whaley-Connell A; DeMarco VG; Lastra G; Manrique C; Nistala R; Cooper SA; Westerly B; Hayden MR; Wiedmeyer C; Wei Y; Sowers JR
Am J Nephrol; 2008; 28(1):67-75. PubMed ID: 17914247
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
20. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
Custodis F; Eberl M; Kilter H; Böhm M; Laufs U
Cardiovasc Res; 2006 Jul; 71(2):342-51. PubMed ID: 16698001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
